TRNS Financials

Income Statement
MetricQ2 2027Q1 2027Q4 2026Q3 2026Q2 2026
Revenue
97.1M
+4.5%
92.9M
+4.1%
89.3M
+6.5%
83.9M
+1.9%
82.3M
Cost of Revenue
64.5M
+3.6%
62.2M
+5.7%
58.9M
+0.4%
58.6M
+5.6%
55.5M
Gross Profit
32.6M
+6.2%
30.7M
+0.9%
30.5M
+20.7%
25.3M
-5.6%
26.8M
Operating Expenses
27.6M
+2.2%
27.0M
+3.4%
26.1M
+3.9%
25.2M
+8.2%
23.3M
R&D
0
0
0
0
0
SG&A
27.6M
+2.2%
27.0M
+3.4%
26.1M
+3.9%
25.2M
+8.2%
23.3M
Operating Income
5.0M
+35.3%
3.7M
-14.2%
4.3M
+4822.7%
88.0K
-97.5%
3.5M
EBITDA
11.9M
+11.2%
10.7M
-5.4%
11.3M
+56.3%
7.2M
-27.8%
10.0M
Net Income
2.4M
+81.3%
1.3M
-31.6%
1.9M
+276.8%
-1101000
-186.8%
1.3M
EPS (Basic)
$0.26
+85.7%
$0.14
-33.3%
$0.21
+275.0%
$-0.12
-185.7%
$0.14
EPS (Diluted)
$0.25
+78.6%
$0.14
-33.3%
$0.21
+275.0%
$-0.12
-185.7%
$0.14
Shares (Diluted)
9.5M
+0.8%
9.5M
+0.7%
9.4M
+0.8%
9.3M
-0.7%
9.4M
Transcat (TRNS) — Financials